Cost-Effectiveness of an Adjuvanted Hepatitis B Vaccine (HEPLISAV-B) in Patients with Inflammatory Bowel Disease

Juan E. Corral, Joshua Y. Kwon, Freddy Caldera, Surakit Pungpapong, Aaron C. Spaulding, Bijan J. Borah, James P. Moriarty, Francis A. Farraye

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Cost-Effectiveness of an Adjuvanted Hepatitis B Vaccine (HEPLISAV-B) in Patients with Inflammatory Bowel Disease'. Together they form a unique fingerprint.

Medicine & Life Sciences